IL97148A - Oxtanones, the process for their preparation and the pharmaceutical preparations containing them - Google Patents

Oxtanones, the process for their preparation and the pharmaceutical preparations containing them

Info

Publication number
IL97148A
IL97148A IL9714891A IL9714891A IL97148A IL 97148 A IL97148 A IL 97148A IL 9714891 A IL9714891 A IL 9714891A IL 9714891 A IL9714891 A IL 9714891A IL 97148 A IL97148 A IL 97148A
Authority
IL
Israel
Prior art keywords
methyl
oxo
oxetanyl
group
alkyl
Prior art date
Application number
IL9714891A
Other languages
English (en)
Hebrew (he)
Other versions
IL97148A0 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL97148A0 publication Critical patent/IL97148A0/xx
Publication of IL97148A publication Critical patent/IL97148A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12—Beta-lactones

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
IL9714891A 1990-02-26 1991-02-05 Oxtanones, the process for their preparation and the pharmaceutical preparations containing them IL97148A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH60490 1990-02-26
CH400590 1990-12-17

Publications (2)

Publication Number Publication Date
IL97148A0 IL97148A0 (en) 1992-05-25
IL97148A true IL97148A (en) 1996-11-14

Family

ID=25685091

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9714891A IL97148A (en) 1990-02-26 1991-02-05 Oxtanones, the process for their preparation and the pharmaceutical preparations containing them

Country Status (18)

Country Link
EP (1) EP0444482B1 (fr)
JP (1) JP2753403B2 (fr)
KR (1) KR0183036B1 (fr)
AT (1) ATE133167T1 (fr)
AU (1) AU645291B2 (fr)
CA (1) CA2035967C (fr)
DE (1) DE59107262D1 (fr)
DK (1) DK0444482T3 (fr)
ES (1) ES2082869T3 (fr)
FI (1) FI115054B (fr)
GR (1) GR3019618T3 (fr)
HU (1) HU218272B (fr)
IE (1) IE72196B1 (fr)
IL (1) IL97148A (fr)
MC (1) MC2226A1 (fr)
NO (1) NO177055C (fr)
NZ (1) NZ237170A (fr)
PT (1) PT96887B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2035972C (fr) * 1990-02-23 2006-07-11 Martin Karpf Procede de preparation d'oxetanones
CA2098167C (fr) * 1992-06-24 2006-12-19 Dorothea Isler Aliments pour humains et animaux contenant un inhibiteur de la lipase
NL1004559C2 (nl) * 1996-11-18 1998-05-19 Unilife Boter.
JP2003524685A (ja) * 1999-10-29 2003-08-19 ムリンズ、ジョーン、ジェイソン、ジェントリー オキセタノン誘導体
US6342519B2 (en) * 1999-10-29 2002-01-29 2 Pro Chemical Oxetanone derivatives
US6348492B1 (en) * 1999-10-29 2002-02-19 2Pro Chemical Oxetanone derivatives
US7074822B2 (en) 2004-02-23 2006-07-11 Solvay Pharmaceuticals Gmbh Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them
DE102004009076A1 (de) * 2004-02-23 2005-10-27 Solvay Pharmaceuticals Gmbh Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US8258321B2 (en) 2007-10-31 2012-09-04 Burnham Institute For Medical Research Beta-lactone compounds
EP3651784B1 (fr) * 2017-07-12 2022-09-28 Mayo Foundation for Medical Education and Research Composés pour la réduction de lésions lipotoxiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
GB2023604B (en) * 1978-05-25 1982-07-28 Microbial Chem Res Found Physiologically active derivatives of esterastin and production thereof
JPH0669130B2 (ja) * 1984-08-09 1994-08-31 三菱電機株式会社 遅延線

Also Published As

Publication number Publication date
CA2035967C (fr) 2001-10-16
NO910729D0 (no) 1991-02-25
FI910925A (fi) 1991-08-27
HU218272B (en) 2000-07-28
DK0444482T3 (da) 1996-05-06
JPH0770099A (ja) 1995-03-14
EP0444482A3 (en) 1991-12-04
IE910631A1 (en) 1991-08-28
HUT56557A (en) 1991-09-30
ES2082869T3 (es) 1996-04-01
IE72196B1 (en) 1997-03-26
PT96887B (pt) 1998-09-30
PT96887A (pt) 1991-10-31
IL97148A0 (en) 1992-05-25
ATE133167T1 (de) 1996-02-15
NO177055C (no) 1995-07-12
FI115054B (fi) 2005-02-28
KR910021391A (ko) 1991-12-20
NO910729L (no) 1991-08-27
KR0183036B1 (ko) 1999-05-01
FI910925A0 (fi) 1991-02-26
AU645291B2 (en) 1994-01-13
GR3019618T3 (en) 1996-07-31
NZ237170A (en) 1993-12-23
JP2753403B2 (ja) 1998-05-20
MC2226A1 (fr) 1993-02-02
EP0444482B1 (fr) 1996-01-17
AU7122891A (en) 1991-08-29
NO177055B (no) 1995-04-03
CA2035967A1 (fr) 1991-08-27
DE59107262D1 (de) 1996-02-29
EP0444482A2 (fr) 1991-09-04

Similar Documents

Publication Publication Date Title
US5260310A (en) Oxetanone compounds and pharmaceutical compositions containing them
RU2108322C1 (ru) Производные циклоалкилзамещенного глутарамида и фармацевтическая композиция на их основе
EP0525420B1 (fr) Pseudopeptides et peptides caractérisés par une partie méthyle cétone substituée à la terminaison C comme inhibiteurs de thiol protéase
US5618844A (en) Hydroxamic acid and carboxylic acid derivatives, process for their preparation and use thereof
DE69432614T2 (de) Alkohol und Aldehyde Derivate als Cathepsin L Inhibitore und als Inhibitore der Knochenresorption
DE2925945C2 (fr)
IL97148A (en) Oxtanones, the process for their preparation and the pharmaceutical preparations containing them
HUT74511A (en) Metalloproteinase inhibitors, pharmaceutical compns. contg. them and process to prepare the said compds.
HRP980096A2 (en) Reverse hydroxamate derivatives as matrix metalloprotease inhibitors, metalloprotease inhibitors, and tnf alpha inhibitors
EP0810221A1 (fr) Derives heterocycliques contenant de l'oxygene
US6444849B1 (en) Amide derivatives
BE1003848A3 (fr) Nouveaux derives de la thiouree, leur preparation et leur utilisation comme medicaments.
EP0520427B1 (fr) Dérivés de la cyclopropénone
WO1995019959A1 (fr) Derives d'acide amine et leur utilisation en tant qu'inhibiteurs de la phospholipase a2
EP0848957A1 (fr) INHIBITEUR DE SOLUBILISATION DE LIGAND Fas
CZ281839B6 (cs) Derivát aminokyseliny, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje
US5506259A (en) β-mercapto-propanamide derivatives useful in the treatment of cardiovascular diseases
US5438046A (en) N-heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases
EP0925786A1 (fr) Agents de traitement des maladies ischemiques
JPS61152663A (ja) オキセタノン類
KR20010020452A (ko) 금속 단백질 분해효소 억제제
JPH09188631A (ja) Ｆａｓリガンド可溶化抑制薬
SA91110250B1 (ar) اوكستانونات oxetanones
JP2000086611A (ja) 新規なメタロプロテイナ―ゼ阻害剤
WO1992001447A1 (fr) Derives d'acide 2-cyclopropylacetique

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed